Immupharma PLC Holding(s) in Company (4832E)
February 09 2018 - 9:00AM
UK Regulatory
TIDMIMM
RNS Number : 4832E
Immupharma PLC
09 February 2018
9 February 2018
ImmuPharma PLC
("ImmuPharma" or the "Company")
Holding in Company
ImmuPharma PLC (LSE: IMM), the specialist drug discovery and
development company, announces that on 8 February 2018 it received
notification that Alto Invest no longer holds a notifiable interest
in the Company.
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) 596/2014.
For further information, please contact:
ImmuPharma plc (www.immupharma.com) +44 (0) 207 152
Tim McCarthy, Chairman 4080
Lisa Baderoon, Head of Investor
Relations +44 (0) 7721 413
lisa.baderoon@immupharma.com 496
-------------------------------------- ------------------
Northland Capital Partners Limited
David Hignell, Jamie Sportswood
(Corporate Finance) +44 (0) 203 861
Rob Rees (Corporate Broking) 6625
-------------------------------------- ------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLXKLFBVLFZBBK
(END) Dow Jones Newswires
February 09, 2018 09:00 ET (14:00 GMT)
Immupharma (LSE:IMM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2023 to Apr 2024